Table 3.
Risk of a fall during follow-up according to drug withdrawal in a cohort of older fallers (n = 139)
| Model 1* | Model 2† | |||
|---|---|---|---|---|
| Drug group | HR | (95% CI) | HR | (95% CI) | 
| All FRID (n = 75) | 0.65 | (0.33, 1.28) | 0.48 | (0.23, 0.99)‡ | 
| CVD (n = 41) | 0.48 | (0.21, 1.09) | 0.35 | (0.15, 0.82)‡ | 
| PTD (n = 29) | 0.71 | (0.31–1.61) | 0.56 | (0.23–1.38) | 
CI confidence interval; FRID fall-risk-increasing drugs; CVD cardiovascular drugs; PTD psychotropic drugs; HR hazard ratio.
Model 1 adjusted for age and gender
Model 2 adjusted for age, gender, FRID use, baseline falls frequency, MMSE-score, number of comorbid conditions, and reason for referral.
P < 0.05